[MODIFICATIONS OF THE INSULO-PANCREATIC FUNCTIONAL ACTIVITY BY PARASYMPATHOLYTIC PHARMACOLOGIC EFFECT IN ESSENTIAL OBESITY].
D001774:Blood Chemical Analysis; D001786:Blood Glucose; D005934:Glucagon; D005951:Glucose Tolerance Test; D007328:Insulin; D062312:Islands; D007515:Islets of Langerhans; D009765:Obesity; D010179:Pancreas; D010276:Parasympatholytics; D010600:Pharmacology
D001786:Blood Glucose; D007328:Insulin; D010276:Parasympatholytics; D005934:Glucagon
BLOOD CHEMICAL ANALYSIS; BLOOD SUGAR; GLUCAGON; GLUCOSE TOLERANCE TEST; INSULIN; ISLANDS OF LANGERHANS; OBESITY; PARASYMPATHOLYTICS; PHARMACOLOGY
MODIFICAZIONI DELL'ATTIVIT'A FUNZIONALE INSULO-PANCREATICA PER EFFETTO FARMACOLOGICO PARASIMPATICOLITICO NELLE OBESIT'A ESSENZIALI.